News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
581,623 Results
Type
Article (20635)
Company Profile (319)
Press Release (560664)
Multimedia
Podcasts (113)
Webinars (15)
Section
Business (194225)
Career Advice (434)
Deals (29848)
Drug Delivery (53)
Drug Development (71215)
Employer Resources (39)
FDA (12231)
Job Trends (10551)
News (284942)
Policy (22148)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (1231)
Accelerated approval (41)
ADA (38)
Adcomms (15)
Allergies (148)
Alliances (41150)
ALS (214)
Alzheimer's disease (1502)
Antibody-drug conjugate (ADC) (528)
Approvals (12814)
Artificial intelligence (578)
ASCO (271)
Autoimmune disease (342)
Automation (36)
Bankruptcy (299)
Best Places to Work (8501)
BIO (65)
BIOSECURE Act (6)
Biosimilars (177)
BioSpace Insights (82)
Biotechnology (226)
Bladder cancer (177)
Brain cancer (62)
Breast cancer (685)
Cancer (5528)
Cardiovascular disease (405)
Career advice (372)
Career pathing (14)
CAR-T (328)
CDC (8)
Celiac Disease (1)
Cell therapy (896)
Cervical cancer (43)
Clinical research (63386)
Collaboration (2033)
Commercialization (6)
Company closure (3)
Compensation (1536)
Complete response letters (76)
COVID-19 (1441)
CRISPR (124)
C-suite (1136)
Cystic fibrosis (144)
Data (7883)
Denatured (26)
Depression (164)
Dermatology (92)
Diabetes (497)
Diagnostics (4820)
Digital health (44)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (351)
Drug pricing (59)
Drug shortages (5)
Duchenne muscular dystrophy (323)
Earnings (80484)
Editorial (37)
Employer branding (6)
Employer resources (37)
Events (103168)
Executive appointments (990)
FDA (15723)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1646)
Gene editing (261)
Generative AI (43)
Gene therapy (722)
GLP-1 (687)
Government (1749)
Grass and pollen (4)
Guidances (335)
Healthcare (11993)
Hematology (147)
HIV (68)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (106)
Immunology and inflammation (280)
Immuno-oncology (98)
Indications (204)
Infectious disease (1700)
Inflammatory bowel disease (205)
Inflation Reduction Act (12)
Influenza (94)
Intellectual property (307)
Interviews (57)
IPO (14363)
IRA (13)
Job creations (2422)
Job search strategy (337)
JPM (41)
Kidney cancer (19)
Labor market (36)
Layoffs (305)
Leadership (15)
Legal (5646)
Licensing (10)
Liver cancer (66)
Longevity (28)
Lung cancer (748)
Lymphoma (399)
Machine learning (46)
Management (9)
Manufacturing (824)
Marketing (12)
MASH (187)
Medical affairs (1)
Medical device (9903)
Medtech (10062)
Mergers & acquisitions (16698)
Metabolic disorders (1232)
mRNA (188)
Multiple sclerosis (158)
NASH (14)
Neurodegenerative disease (439)
Neuropsychiatric disorders (100)
Neuroscience (3017)
Neurotech (1)
NextGen: Class of 2026 (4128)
Non-profit (1514)
Now hiring (42)
Obesity (515)
Opinion (151)
Ovarian cancer (225)
Pain (228)
Pancreatic cancer (315)
Parkinson's disease (373)
Partnered (21)
Patents (585)
Patient recruitment (770)
Peanut (55)
People (49518)
Pharmaceutical (50)
Pharmacy benefit managers (13)
Phase 1 (20941)
Phase 2 (28621)
Phase 3 (19415)
Pipeline (9423)
Policy (116)
Postmarket research (1891)
Preclinical (8947)
Press Release (52)
Prostate cancer (292)
Psychedelics (74)
Radiopharmaceuticals (342)
Rare diseases (1107)
Real estate (3774)
Recruiting (14)
Regulatory (19407)
Reports (31)
Research institute (1322)
Resumes & cover letters (59)
Rett syndrome (48)
RNA editing (31)
RSV (57)
Schizophrenia (171)
Series A (305)
Series B (220)
Service/supplier (5)
Sickle cell disease (117)
Special edition (21)
Spinal muscular atrophy (143)
Sponsored (20)
Startups (3114)
State (1)
Stomach cancer (8)
Supply chain (72)
Tariffs (19)
The Weekly (85)
Vaccines (565)
Venture capital (105)
Weight loss (264)
Women's health (102)
Worklife (2)
Date
Today (112)
Last 7 days (653)
Last 30 days (2135)
Last 365 days (25932)
2026 (16191)
2025 (25756)
2024 (30026)
2023 (33976)
2022 (43314)
2021 (45731)
2020 (40883)
2019 (29829)
2018 (22460)
2017 (24179)
2016 (22652)
2015 (28865)
2014 (24869)
2013 (20673)
2012 (22487)
2011 (22746)
2010 (22422)
Location
Africa (337)
Alabama (91)
Alaska (3)
Arizona (335)
Arkansas (14)
Asia (28916)
Australia (4444)
California (13599)
Canada (3705)
China (1301)
Colorado (556)
Connecticut (527)
Delaware (368)
Europe (53891)
Florida (1979)
Georgia (409)
Hawaii (4)
Idaho (47)
Illinois (921)
India (80)
Indiana (439)
Iowa (17)
Japan (534)
Kansas (115)
Kentucky (36)
Louisiana (41)
Maine (37)
Maryland (1433)
Massachusetts (9855)
Michigan (317)
Minnesota (628)
Mississippi (5)
Missouri (94)
Montana (32)
Nebraska (14)
Nevada (131)
New Hampshire (75)
New Jersey (3172)
New Mexico (18)
New York (3358)
North Carolina (1659)
North Dakota (9)
Northern California (6956)
Ohio (341)
Oklahoma (15)
Oregon (34)
Pennsylvania (2661)
Puerto Rico (24)
Rhode Island (37)
South America (526)
South Carolina (77)
South Dakota (1)
Southern California (5411)
Tennessee (143)
Texas (2170)
United States (46036)
Utah (398)
Vermont (1)
Virginia (243)
Washington D.C. (51)
Washington State (1095)
West Virginia (2)
Wisconsin (105)
581,623 Results for "xylocor therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
XyloCor Appoints John Tucker as President and Chief Executive Officer
March 5, 2026
·
2 min read
Press Releases
First Patient Dosed in XyloCor Therapeutics’ Phase 2b EXACT-2 Trial Evaluating XC001 for the Treatment of Coronary Artery Disease
July 10, 2025
·
6 min read
Pharm Country
XyloCor Therapeutics Positive EXACT Phase 2 Data for Lead Candidate XC001 Simultaneously Presented at Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions
XyloCor Therapeutics Positive EXACT Phase 2 Data for Lead Candidate XC001 Simultaneously Presented at Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions and Published in Circulation: Cardiovascular Interventions.
May 2, 2024
·
6 min read
Press Releases
XyloCor Therapeutics Raises $67.5 Million in Series B Financing to Advance Clinical Development of Novel Gene Therapy in Cardiovascular Disease
January 7, 2025
·
5 min read
Drug Development
Results from XyloCor Therapeutics’ Phase 1 Portion of EXACT Trial of XC001 for Cardiovascular Disease Published in Circulation: Cardiovascular Interventions
Results from XyloCor Therapeutics’ Phase 1 Portion of EXACT Trial of XC001 for Cardiovascular Disease Published in Circulation: Cardiovascular Interventions.
August 3, 2023
·
5 min read
Drug Development
XyloCor Therapeutics Presents Phase 2 Data Highlighting Safety and Efficacy of XC001 at the European Society of Cardiology (ESC) Congress 2023
XyloCor Therapeutics, Inc. presented results from the Phase 2 portion of its Phase 1/2 clinical trial of its lead gene therapy candidate XC001 for refractory angina at the European Society of Cardiology Congress 2023.
August 25, 2023
·
5 min read
Press Releases
Definium Therapeutics, Inc. Announces Proposed Public Offering
June 23, 2026
·
6 min read
Press Releases
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 4, 2026
·
3 min read
Drug Development
XyloCor Advances Cardiovascular Gene Therapy Space with Positive Angina Results
XyloCor Therapeutics reported positive topline results Thursday from Phase II of the Phase I/II trial of its gene therapy for refractory angina.
January 27, 2023
·
2 min read
·
Heather McKenzie
Press Releases
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
June 19, 2026
·
5 min read
1 of 58,163
Next
